Time & Date: 4 September, 09:15 – 10:15 CEST
Moderator: M. Iglicki ARGENTINA
Speakers & Presentations:
M. Iglicki ARGENTINA
09:15 Welcome
D. Wright UK
09:17 Interpretable machine learning to identify visual function measures which distinguish age-related macular degeneration stage and diabetic retinopathy status.
H. Khalid UK
09:22 Association between obesity and retinal fractal dimension as an indicator of microvascular changes
M. Iglicki ARGENTINA
09:27 Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study
J.I. Fernandez-Vigo SPAIN
09:32 Intervortex venous anastomosis in the macula in central serous chorioretinopathy by en face optical coherence tomography.
J. Iby AUSTRIA
09:37 Morphologic and demographic prediction of chronification of central serous chorioretinopathy
J. Brinks THE NETHERLANDS
09:42 Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy
L. Cehofski DENMARK
09:47 Identification of Aqueous Humor Biomarkers in Central Retinal Vein Occlusion – A Proteome Study
J. Shankar UK
09:52 Interruption of AMD treatment during Covid-19 lockdown : Have clinical outcomes been compromised?
J. Donate-López PSAIN
09:57 Refinement of a screening algorithm based on artificial intelligence for the detection of Diabetic Retinopathy in real clinical practice
All Faculty
10:02 Discussion
